Selvita S.A. SLV.WA Stock
Selvita S.A. Price Chart
Selvita S.A. SLV.WA Financial and Trading Overview
Selvita S.A. stock price | 71.8 PLN |
Previous Close | 70 PLN |
Open | 69.1 PLN |
Bid | 68.7 PLN x N/A |
Ask | 69.4 PLN x N/A |
Day's Range | 68.6 - 70.5 PLN |
52 Week Range | 67 - 91.6 PLN |
Volume | 3.09K PLN |
Avg. Volume | 9.42K PLN |
Market Cap | 1.27B PLN |
Beta (5Y Monthly) | 0.025577 |
PE Ratio (TTM) | 42.592594 |
EPS (TTM) | 3.8 PLN |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 92.5 PLN |
SLV.WA Valuation Measures
Enterprise Value | 1.46B PLN |
Trailing P/E | 42.592594 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.9902506 |
Price/Book (mrq) | 4.6894116 |
Enterprise Value/Revenue | 3.443 |
Enterprise Value/EBITDA | 24.02 |
Trading Information
Selvita S.A. Stock Price History
Beta (5Y Monthly) | 0.025577 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 91.6 PLN |
52 Week Low | 67 PLN |
50-Day Moving Average | 71.62 PLN |
200-Day Moving Average | 78.47 PLN |
SLV.WA Share Statistics
Avg. Volume (3 month) | 9.42K PLN |
Avg. Daily Volume (10-Days) | 8.21K PLN |
Shares Outstanding | 18.36M |
Float | 13.08M |
Short Ratio | N/A |
% Held by Insiders | 21.76% |
% Held by Institutions | 29.32% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 6.57% |
Operating Margin (ttm) | 10.29% |
Gross Margin | 83.27% |
EBITDA Margin | 14.33% |
Management Effectiveness
Return on Assets (ttm) | 5.10% |
Return on Equity (ttm) | 12.62% |
Income Statement
Revenue (ttm) | 423.55M PLN |
Revenue Per Share (ttm) | 23.08 PLN |
Quarterly Revenue Growth (yoy) | 9.19% |
Gross Profit (ttm) | N/A |
EBITDA | 60.7M PLN |
Net Income Avi to Common (ttm) | 28.9M PLN |
Diluted EPS (ttm) | 1.62 |
Quarterly Earnings Growth (yoy) | -50.00000000000000000000000000000000% |
Balance Sheet
Total Cash (mrq) | 51.44M PLN |
Total Cash Per Share (mrq) | 2.8 PLN |
Total Debt (mrq) | 224.68M PLN |
Total Debt/Equity (mrq) | 83.19 PLN |
Current Ratio (mrq) | 1.375 |
Book Value Per Share (mrq) | 14.714 |
Cash Flow Statement
Operating Cash Flow (ttm) | 55.7M PLN |
Levered Free Cash Flow (ttm) | -28111278 PLN |
Profile of Selvita S.A.
Country | Poland |
State | N/A |
City | Kraków |
Address | Bobrzynskiego 14 |
ZIP | 30-348 |
Phone | 48 122 97 47 00 |
Website | https://selvita.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 847 |
Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, analytical and solid state chemistry, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, inflammation, and fibrosis. In addition, the company provides drug development services, including development, validation, and transfer; quality control; small molecules analytical testing; stability testing; elemental impurities testing; pharmaceutical impurities identification, determination, and testing; nitrosamines determination and testing; pyrrolizidine alkaloids determination and testing; cleaning validation; bioequivalence; analytical support and equipment; ICH Q6B testing; physicochemical properties determination; binding properties and potency assays; therapeutic proteins production and development services. Further, it offers research and development services in the areas of agrochemistry analytical support, flavor and fragrance, and chemotypes. The company has a collaboration agreement with The University of Oxford to advance potential therapeutics for Parkinson's disease. Selvita S.A. was founded in 2007 and is headquartered in Kraków, Poland.
Q&A For Selvita S.A. Stock
What is a current SLV.WA stock price?
Selvita S.A. SLV.WA stock price today per share is 71.8 PLN.
How to purchase Selvita S.A. stock?
You can buy SLV.WA shares on the Warsaw exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Selvita S.A.?
The stock symbol or ticker of Selvita S.A. is SLV.WA.
Which industry does the Selvita S.A. company belong to?
The Selvita S.A. industry is Diagnostics & Research.
How many shares does Selvita S.A. have in circulation?
The max supply of Selvita S.A. shares is 18.36M.
What is Selvita S.A. Price to Earnings Ratio (PE Ratio)?
Selvita S.A. PE Ratio is 18.89473700 now.
What was Selvita S.A. earnings per share over the trailing 12 months (TTM)?
Selvita S.A. EPS is 3.8 PLN over the trailing 12 months.
Which sector does the Selvita S.A. company belong to?
The Selvita S.A. sector is Healthcare.